[ Page 02 ] About Bacospore®

Bacospore®: A strain-specific, spore-forming probiotic.

Bacospore® is a high-potency probiotic developed for supplements, nutraceuticals and functional foods. It contains viable spores of Heyndrickxia coagulans, formerly Bacillus coagulans, combining probiotic functionality with the stability advantages of a bacterial endospore.

01 · What is Bacospore®

A deposited, spore-forming probiotic strain.

Bacospore® is a probiotic preparation containing the Gram-positive, lactic acid-producing bacterium Heyndrickxia coagulans, commonly known as Bacillus coagulans. The organism is rod-shaped, catalase-positive, facultatively anaerobic and capable of forming highly resistant endospores.

The Bacospore® strain has been deposited with the Microbial Type Culture Collection and Gene Bank, India, as MTCC 25308, and with the American Type Culture Collection as PTA-126364, providing strain-level identification and traceability.

Bacospore® is standardized by viable spore count rather than by a botanical marker. The documented Bacospore® 300B grade provides not less than 300 billion viable spores per gram and uses tapioca-derived maltodextrin as the excipient.

02 · Differentiation

What makes Bacospore® different.

Strain-specific identity

Probiotic properties are strain-dependent. Bacospore® is identified as B. coagulans MTCC 25308, distinguishing it from generic species-only materials.

Spore-forming stability

Protective endospores help the organism tolerate elevated temperatures, gastric acidity and bile salts, supporting stability through storage, processing and GI transit.

Controlled fermentation

Manufactured through controlled fermentation and standardized to viable spore count, with identity, potency, moisture, microbiological and heavy-metal specifications.

Multifunctional research

Peer-reviewed research on MTCC 25308 has examined gastrointestinal, metabolic and cellular-protective activities across animal, cellular and laboratory models.

03 · Salient features

At a glance.

  • Strain-specific Bacillus coagulans MTCC 25308
  • Also identified as Heyndrickxia coagulans
  • Deposited as MTCC 25308 and ATCC PTA-126364
  • Gram-positive, rod-shaped and spore-forming
  • Standardized to viable spore count
  • Bacospore® 300B provides ≥300 billion spores/g
  • Stable spore format for nutraceutical development
  • Water-soluble in the 300B specification
  • Produced through controlled fermentation
  • GMO-free and BSE/TSE-free
  • Non-irradiated · not treated with ETO
  • Two-year shelf life (Bacospore® 300B)
04 · Specifications

Specifications at a glance.

MicroorganismHeyndrickxia coagulans (formerly Bacillus coagulans)
StrainMTCC 25308
Additional depositATCC PTA-126364
Commercial grade referencedBacospore® 300B
Standardization≥ 300 billion viable spores/g
Manufacturing processControlled fermentation
ExcipientTapioca-derived maltodextrin
AppearanceLight brown to dark brown powder, characteristic odour
SolubilitySoluble in water
Loss on dryingNot more than 5.0%
Shelf lifeTwo years
GMO statusGMO-free
BSE/TSE statusBSE/TSE-free
Processing statusNon-irradiated · not treated with ETO
Country of originIndia

The Bacospore® 300B specification also establishes limits for lead, arsenic, cadmium and mercury, plus limits for yeast and mould, Salmonella, E. coli, Staphylococcus aureus and Pseudomonas aeruginosa.

05 · Applications

Where Bacospore® fits.

Dietary supplement capsules and tablets
Sachets and powdered supplement blends
Digestive health formulations
Gut microbiome support products
Immune-support formulations
Functional foods and nutritional products
Metabolic wellness formulations
Multi-strain probiotic combinations

Its spore-forming nature, water solubility and high viable count provide formulation flexibility. Compatibility, processing survival and viable count through end of shelf life should be validated in the finished product.

Evaluate Bacospore® in your next formulation.